The withdrawal follows a series of regulatory actions overseas centred on the drug's pivotal ADVOCATE trial and a growing liver-injury safety signal.

Visit-to-visit systolic blood pressure variability can independently predict the risk for mortality among patients with ...

Faricimab showed a positive treatment effect for up to 6 months in patients with macular edema due to retinal vein occlusion, according to data published in Ophthalmology and Therapy. “Due to the very ...

A North Texas woman is speaking out after surviving vasculitis, a rare and potentially deadly illness. She is now sharing her ...

A prospective study of forty Turkish children with IgA vasculitis finds that elevated neutrophil-to-lymphocyte ratio, serum ...

A North Texas woman shares her story of survival against rare vasculitis and acute lung failure thanks to advanced life ...

The poster is scheduled for October 22, 2026, during the American Society of Nephrology's Kidney Week in Denver. The program ...

Avacopan (Tavneos), the complement pathway inhibitor for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis ...

A vote taken by the sound of applause rang out during an early morning session at (AAO) 2026 annual meeting, where 2 experts discussed the pros and cons of using complement inhibitors to treat ...

A retrospective study from The Ohio State University finds that truncal rash distribution, older age, and smoking help ...

In the first reported case of the autoinflammatory VEXAS syndrome in South Africa, J Damelin, J Jacobson, C Bam, L Pillay and ...

MELBOURNE, Australia and BASEL, Switzerland, Oct. 5, 2026 /PRNewswire/ -- CSL and Alentis Therapeutics today announced they have entered into an exclusive global collaboration agreement to co-develop ...